Effect of Acetylcysteine Inhalation on Incidence and Time to Develop Ventilator Associated Pneumonia in Critically Ill Mechanically Ventilated Patients

NCT07409727 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Ventilation Acquired Pneumonia

Interventions

DRUG: Acetyl cysteine
DRUG: Normal (0.9%) saline

Sponsor

Sarah Rabie Mohamed Adly